WC
Westhampton Capital Portfolio holdings
AUM $194M
1-Year Return
15.87%
This Quarter Return
+13.36%
1 Year Return
+15.87%
3 Year Return
+72.22%
5 Year Return
+130.64%
10 Year Return
–
AUM
$134M
AUM Growth
+$11.7M
(+9.6%)
Cap. Flow
-$2.22M
Cap. Flow
% of AUM
-1.66%
Top 10 Holdings %
Top 10 Hldgs %
38.88%
Holding
105
New
3
Increased
24
Reduced
49
Closed
2
Top Buys
| 1 |
Wells Fargo
WFC
|
+$253K |
| 2 |
TransDigm Group
TDG
|
+$249K |
| 3 |
IBM
IBM
|
+$219K |
| 4 |
iShares Biotechnology ETF
IBB
|
+$202K |
| 5 |
Unilever
UL
|
+$114K |
Top Sells
| 1 |
Biogen
BIIB
|
+$471K |
| 2 |
CVS Health
CVS
|
+$260K |
| 3 |
Gilead Sciences
GILD
|
+$235K |
| 4 |
Procter & Gamble
PG
|
+$229K |
| 5 |
Deere & Co
DE
|
+$221K |
Sector Composition
| 1 | Consumer Staples | 25.56% |
| 2 | Industrials | 20.57% |
| 3 | Technology | 17.93% |
| 4 | Consumer Discretionary | 8.88% |
| 5 | Healthcare | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
FNB Corp
FNB
$5.83B
| $99K | 0.07% |
10,383
| – | – |
|
|
PEI
102
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $15K | 0.01% |
1,000
| – | – |
|
|
BMY.RT
103
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $8K | 0.01% |
11,150
-2,000
| -15% | -$1.44K |
|
|
104
Biogen
BIIB
$21B
| – | – |
-1,660
| Closed | -$471K |
|
105
FedEx
FDX
$53.3B
| – | – |
-867
| Closed | -$218K |
|